Correction: A pair of promising immune checkpoints PSGL-1 and VISTA from immunotolerance to immunotherapy

Correction: A pair of promising immune checkpoints PSGL-1 and VISTA from immunotolerance to immunotherapy

Saved in:

Bibliographic Details
Main Authors:	Manqing Peng, Xiaofang Lu, Junshuang Guo, Xiangli Yin, Jing Zhang, Xin Li, Yizhou Zou
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	Biomarker Research
Online Access:	https://doi.org/10.1186/s40364-024-00709-3
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A pair of promising immune checkpoints PSGL-1 and VISTA from immunotolerance to immunotherapy
by: Manqing Peng, et al.
Published: (2024-12-01)

Chidamide functions as a VISTA/PSGL-1 blocker for cancer immunotherapy
by: Xiaoshuang Niu, et al.
Published: (2025-02-01)

VISTA immune checkpoint blunts radiotherapy-induced antitumor immune response
by: Dhanya K. Nambiar, et al.
Published: (2025-07-01)

Generation of donor-specific immunotolerance in renal-allograft recipients
by: V. A. Goryainov, et al.
Published: (2018-08-01)

The role of immunotolerance in immunosuppressive therapy after liver transplantation
by: E. Yu. Anosova, et al.
Published: (2024-09-01)

Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review
by: Whitney Faiella, et al.
Published: (2016-01-01)

CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS
by: A. V. Bogolyubova, et al.
Published: (2015-10-01)

Tumor glyco-immunology, glyco-immune checkpoints and immunotherapy
by: Heinz Läubli, et al.
Published: (2025-06-01)

Intra-host emergence of an enterovirus A71 variant with enhanced PSGL1 usage and neurovirulence
by: Liang Sun, et al.
Published: (2019-01-01)

Immune Checkpoint Molecules: A Review on Pathways and Immunotherapy Implications
by: Erfan Rezazadeh‐Gavgani, et al.
Published: (2025-04-01)

VISTA functions as a protective immune checkpoint in indirect acute respiratory distress syndrome by modulating systemic and compartmentalized inflammation
by: Baoji Hu, et al.
Published: (2025-07-01)

Immunotherapeutic Potential of Lactobacillus Species as Immune Checkpoint Inhibitors in Cancer Immunotherapy
by: Renukadevi J, et al.
Published: (2025-01-01)

Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response
by: Assia Hijazi, et al.
Published: (2023-12-01)

Nanomaterials and immune checkpoint inhibitors in cancer immunotherapy: the synergistic innovation prospects
by: Jing Chen, et al.
Published: (2025-06-01)

Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies
by: Samira Anvari, et al.
Published: (2024-12-01)

Potential predictive biomarkers in antitumor immunotherapy: navigating the future of antitumor treatment and immune checkpoint inhibitor efficacy
by: Xiangyu Yin, et al.
Published: (2024-11-01)

VISTA-mediated immune evasion in cancer
by: Raymond J. Zhang, et al.
Published: (2024-11-01)

Correction: Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
Published: (2021-10-01)

Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy
by: MariaLuisa Vigano, et al.
Published: (2025-03-01)

Post-translational modifications of immune checkpoints: unlocking new potentials in cancer immunotherapy
by: Qiongjie Hu, et al.
Published: (2025-03-01)

Optimizing Immunotherapy: The Synergy of Immune Checkpoint Inhibitors with Artificial Intelligence in Melanoma Treatment
by: Mohammad Saleem, et al.
Published: (2025-04-01)

Synergy of oncolytic adenovirus and immune checkpoint inhibitors: transforming cancer immunotherapy paradigms
by: Chong Cheng, et al.
Published: (2025-07-01)

Correction: Efficacy of immune checkpoint inhibitors for in-transit melanoma
Published: (2020-10-01)

Boosting cancer immunotherapy: drug delivery systems leveraging ferroptosis and immune checkpoint blockade
by: Ting Zhang, et al.
Published: (2025-06-01)

Targeting the Adenosine‐Mediated Metabolic Immune Checkpoint with Engineered Probiotic for Enhanced Chemo‐Immunotherapy
by: Jinhui Wang, et al.
Published: (2025-04-01)

New horizons in B-cell lymphoma immunotherapy: From immune checkpoints to precision medicine
by: RuiXin Zheng, et al.
Published: (2025-09-01)

Concurrent immune checkpoint blockade for enhanced cancer immunotherapy utilizing engineered hybrid nanovesicles
by: Yuxuan Liu, et al.
Published: (2024-11-01)

Advances in immunotherapy for mucosal melanoma: harnessing immune checkpoint inhibitors for improved treatment outcomes
by: Zexing Shan, et al.
Published: (2024-07-01)

Prostate cancer immunotherapy-based strategies: an updated review emphasizing immune checkpoint inhibitors
by: Hua Lu, et al.
Published: (2025-06-01)

Recent advances in novel tumor immunotherapy strategies based on regulating the tumor microenvironment and immune checkpoints
by: Hanhui Jing, et al.
Published: (2025-06-01)

Turning Cancer Immunotherapy to the Emerging Immune Checkpoint TIGIT: Will This Break Through the Limitations of the Legacy Approach?
by: Haozhe Cui, et al.
Published: (2024-11-01)

Noninvasive Imaging of Immune Checkpoint Ligand PD-L1 in Tumors and Metastases for Guiding Immunotherapy
by: Samit Chatterjee PhD, et al.
Published: (2017-07-01)

Immune-checkpoint targeting drug conjugates: a novel class of promising therapeutic agents for cancer treatment
by: Silvia Marchesi, et al.
Published: (2025-07-01)

VISTA is a potential target for immunotherapy in B-cell acute lymphoblastic leukemia in children
by: Nourhan K Mohamed, et al.
Published: (2025-07-01)

METTL3-VISTA axis-based combination immunotherapy for APC truncation colorectal cancer
by: Hui Wang, et al.
Published: (2024-12-01)

Serum β2-MG, sCHE, and PSGL-1 Expression in Patients with Esophageal Cancer and Their Association with Postoperative Lung Infection After Mediastinoscopy
by: Yu FENG, et al.
Published: (2025-01-01)

Correction: Acute kidney injury in patients treated with immune checkpoint inhibitors
Published: (2023-04-01)

Microbiota boost immunotherapy? A meta-analysis dives into fecal microbiota transplantation and immune checkpoint inhibitors
by: Anqi Lin, et al.
Published: (2025-06-01)

Preclinical models of immune checkpoint inhibitors-related interstitial pneumonia for anti-PD1 tumor immunotherapy
by: Tingyue Luo, et al.
Published: (2025-03-01)

Exploring the predictive “psycho-biomarkers” for checkpoint immunotherapy in cancer
by: Qian Zuo, et al.
Published: (2025-07-01)